TARA DRAEHN: Open Payments
NPI 1194315739 · WILLIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,565 in 64 payments from 14 companies in 2025. Trend: 2023 $16,656 · 2024 $5,716 · 2025 $4,565
Speaker / faculty: $3,350Food & beverage: $1,152Travel & lodging: $63
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $3,620 |
| Amgen Inc. | 11 | $263 |
| Dexcom, Inc. | 12 | $247 |
| AstraZeneca Pharmaceuticals LP | 6 | $146 |
| Astellas Pharma US Inc | 2 | $58 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Lilly USA, LLC | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $21 |
Products named: UBRELVY, Dexcom G6 Transmitter, REPATHA, OTEZLA, QULIPTA, FARXIGA, VRAYLAR, Veozah.
Industry payments across TX — which companies pay providers there.
